Monopar Therapeutics stock resistance test: Key levels to watch
Monopar Therapeutics (MNPR) stock is trading at $114.33, up 3.17% on the day and closing near the session’s high. The move lifts the stock above its key moving averages, marking relative strength on both short- and long-term timeframes.
Highlights
- MNPR/USD is trading above key short-, medium-, and long-term moving averages, indicating trend strength across all timeframes.
- Momentum indicators give mixed signals with most showing weak or negative momentum and limited buying pressure.
- Expected trading range for the next 2 to 3 days is $106.2315 to $122.4385, with support at $111.615 and resistance at $122.44.
Mixed momentum as price holds above technical supports
On the technical side, MNPR is trading above the MA-20, MA-50, and MA-200, with the daily Ichimoku Kijun line at $111.61 marking immediate support. Short-term resistance stands at $122.44, while the next key support sits at $106.23. Among momentum indicators, MACD and Awesome Oscillator are both signaling strong sell, ADX and CCI are neutral, the RSI prints 42.3, and Stoch RSI generates additional sell signals. Bull/Bear Power remains oversold, highlighting recent dominance by sellers, despite high intraday volatility and an up-close.
Range-bound outlook as breakout odds remain balanced
Over the next 2–3 trading days, price is likely to consolidate within a volatility band of $106.23 to $122.44. The probability of an upward breakout is only slightly higher at 52%, with a downside reversal still possible at 48%. A close above $122.44 would signal the start of a bullish leg, while a breakdown below $111.61 could expose $106.23 as the next downside target.
Earlier, analysts noted that Monopar Therapeutics was experiencing short-term selling pressure despite maintaining longer-term technical strength. The latest action signals technical stabilization above key moving averages, with $122.44 emerging as the pivotal resistance level traders should monitor for confirmation of renewed upside momentum.